Latest Financials News

Catalina Resources unveils a revitalised strategy targeting gold, rare earths, and lithium across Western Australia’s underexplored regions, backed by strong leadership and a solid cash position.

WAM Income Maximiser Limited (WMX) has outperformed its benchmark since its IPO, fully deploying capital ahead of schedule and delivering increasing monthly fully franked dividends.

Pacific Current Group has announced an on-market buy-back of up to 2 million shares, representing nearly 7% of its capital, aiming to enhance earnings per share and capital efficiency.

Eclipse Metals announces plans for a NASDAQ dual listing to boost its rare earth elements strategy and tap into North American capital markets, while maintaining its ASX presence.

Audeara Limited has landed its maiden purchase order for hearing aid technology in China, marking a pivotal step in its global expansion with production and launch planned for the final quarter of 2025.

Beamtree Holdings has reported a 9% increase in recurring revenue for Q1 FY26, driven by strong contract wins and international expansion, including a key UK NHS partnership and a new autonomous coding rollout.

Vital Metals has locked in firm commitments for an extra $5.6 million placement, building on its August raise, to accelerate development of its Tardiff rare earths deposit in Canada.

Compumedics has secured a $2.15 million placement to fast-track commercialisation of its Somfit D device following early FDA approval, positioning the company for significant growth in the US home sleep testing market.

Origin Energy reported a robust FY25 with a $1.48 billion profit and increased dividends, while reaffirming its commitment to net zero emissions by 2050 through its updated Climate Transition Action Plan.

Great Dirt Resources reports promising lithium soil anomalies in Western Australia's Pilbara region and progresses manganese exploration in New South Wales, supported by a solid cash position of $2.4 million.

Cann Group Limited has extended the expiry of its National Australia Bank debt facilities by one year to October 2025, maintaining current terms while exploring long-term refinancing options.

Emyria has secured a multi-year funding extension with Medibank to launch its Empax mental health programs in Brisbane, marking a key step in its national expansion. This insurer-backed initiative aims to improve access to treatment for complex conditions like treatment-resistant depression and PTSD.